HRCM
ETON icon

Hood River Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Hood River Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-73,800
Closed -$540K – 119
2021
Q1 		$540K Sell
73,800
-2,597
-3% -$22.2K 0.02% 112
2020
Q4 		$621K Buy
+76,397
New +$589K 0.02% 99

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Hood River Capital Management's ETON Position: Q2 2021 in Review

Hood River Capital Management sold out of Eton Pharmaceutcials (ETON) in Q2 2021, closing a stake of 73,800 shares — an estimated $540K sold.

Hood River Capital Management first reported a position in ETON in Q4 2020 and held it in 2 quarters. The position peaked at $621K in Q4 2020. 46 funds tracked by Wall St. Rank hold ETON as of Q2 2021.

  • Hood River Capital Management reported no remaining Eton Pharmaceutcials position as of Q2 2021 after selling out during the quarter.
  • Hood River Capital Management sold 73,800 Eton Pharmaceutcials shares in Q2 2021, an estimated $540K.
  • Hood River Capital Management first reported a position in Eton Pharmaceutcials in Q4 2020 and held it in 2 quarters.
  • Hood River Capital Management's Eton Pharmaceutcials position peaked at $621K in Q4 2020.
  • 46 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2021.

Based on Hood River Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.